The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Growth Hormone-Releasing Hormone-Producing Tumors: Clinical, Biochemical, and Morphological Manifestations*
Abstract
This paper has reviewed current knowledge of clinical, biochemical, and morphological manifestations of extracranial GRH-producing tumors. Excessive GRH release stimulates pituitary somatotrophs causing elevation of blood GH levels and acromegaly. In some patients with GRH-containing tumor, blood GH concentrations are normal and no acromegaly develops. GRH-producing tumors associated with acromegaly are rare. Based on a critical analysis of the literature, 30 tumors are accepted as definitive. They possess unique features: occurrence in young age, female preponderance, foregut derivation, benign biological behavior, small secretory granules, and frequent association with MEN type I syndrome. The pancreas and lung are common primary sites. GRH-containing tumors unassociated with acromegaly include those of gut and thymus, small cell carcinoma of lung, and medullary carcinoma of thyroid. Several tumors are plurihormonal. In contrast to somatotroph adenoma seen in patients with classical acromegaly, the hypophysial lesion represents somatotroph hyperplasia in acromegalic patients with GRH-producing tumor. This finding indicates that GRH not only increases somatotroph secretory activity but causes somatotroph proliferation. Studies of GRH-producing tumors are of fundamental importance in obtaining a deeper insight into endocrine activity of pituitary somatotrophs and the pathogenesis of GH-secreting pituitary adenomas associated with acromegaly; the importance of GRH in the etiology of acromegaly is still unresolved. The relationship between GRH-secreting tumors and MEN type I syndrome is controversial; further studies are required to elucidate whether they represent two distinct entities or whether GRH-producing tumors accompanied by acromegaly are only forme fruste manifestations of MEN type I syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., & Wehrenberg, W. B. (1982) · Science · doi:10.1126/science.6812220 · Cited by 1,294
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour
Rivier, J., Spiess, J., Thorner, M., & Vale, W. (1982) · Nature · doi:10.1038/300276a0 · Cited by 1,104
Growth Hormone-Releasing Hormone*
FROHMAN, L. A., & JANSSON, J.-O. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-3-223 · Cited by 427
Thorner, M. O., Perryman, R. L., Cronin, M. J., Rogol, A. D., Draznin, M., Johanson, A., Vale, W., Horvath, E., & Kovacs, K. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110708 · Cited by 393
Self-citationGrowth hormone-releasing factor stimulates proliferation of somatotrophs in vitro.
Billestrup, N., Swanson, L. W., & Vale, W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.6854 · Cited by 325
Ling, N., Esch, F., Böhlen, P., Brazeau, P., Wehrenberg, W. B., & Guillemin, R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4302 · Cited by 291
Immunohistochemical detection of growth hormone-releasing factor in brain
Bloch, B., Brazeau, P., Ling, N., Bohlen, P., Esch, F., Wehrenberg, W. B., Benoit, R., Bloom, F., & Guillemin, R. (1983) · Nature · doi:10.1038/301607a0 · Cited by 258
Carcinoids associated with multiple endocrine neoplasia syndromes
Duh, Q.-Y., Hybarger, C. P., Geist, R., Gamsu, G., Goodman, P. C., Gooding, G. A. W., & Clark, O. H. (1987) · The American Journal of Surgery · doi:10.1016/0002-9610(87)90305-9 · Cited by 189
Familial Multiple Endocrine Neoplasia Type I: A New Look at Pathophysiology
BRANDI, M. L., MARX, S. J., AURBACH, G. D., & FITZPATRICK, L. A. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-4-391 · Cited by 185
Vance, M. L., Kaiser, D. L., Evans, W. S., Furlanetto, R., Vale, W., Rivier, J., & Thorner, M. O. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111864 · Cited by 176
Cited by
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
Rindi, G., Mete, O., Uccella, S., Basturk, O., La Rosa, S., Brosens, L. A. A., Ezzat, S., de Herder, W. W., Klimstra, D. S., Papotti, M., et al. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09708-2 · Cited by 1,036
Self-citationGastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
Overview of the 2022 WHO Classification of Pituitary Tumors
Asa, S. L., Mete, O., Perry, A., & Osamura, R. Y. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09703-7 · Cited by 641
Self-citationEndocrine tumours of the pancreas
Öberg, K., & Eriksson, B. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.06.002 · Cited by 543
Mechanisms for pituitary tumorigenesis: the plastic pituitary
Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320401 · Cited by 456
Metadata
- Authors
- SANO, T., ASA, S. L., & KOVACS, K.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1988-08
- Volume
- 9
- Issue
- 3
- Pages
- 357-373
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2009808471
- Cited by
- 268
- References
- 32
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Growth Hormone-Releasing Hormone-Producing Tumors: Clinical, Biochemical, and Morphological Manifestations*. https://app.cochat.ai/papers/10.1210/edrv-9-3-357
- The paper
- SANO, T., ASA, S. L., & KOVACS, K. (1988). Growth Hormone-Releasing Hormone-Producing Tumors: Clinical, Biochemical, and Morphological Manifestations*. Endocrine Reviews. https://doi.org/10.1210/edrv-9-3-357
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.